These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6309449)

  • 1. Immunological control of Epstein-Barr virus-transformed lymphocytes in multiple sclerosis.
    Craig JC; Haire M; Millar JH; Fraser KB; Merrett JD
    Clin Immunol Immunopathol; 1983 Oct; 29(1):86-93. PubMed ID: 6309449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell-mediated suppression of Epstein-Barr virus-induced B lymphocyte activation in multiple sclerosis.
    Craig JC; Haire M; Merrett JD
    Clin Immunol Immunopathol; 1988 Sep; 48(3):253-60. PubMed ID: 2841052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsets of T lymphocytes in relation to T lymphocyte function in multiple sclerosis.
    Craig JC; Hawkins SA; Swallow MW; Lyttle JA; Patterson VH; Merrett JD; Haire M
    Clin Exp Immunol; 1985 Sep; 61(3):548-55. PubMed ID: 3000660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A positive correlation between the precursor frequency of cytotoxic lymphocytes to autologous Epstein-Barr virus-transformed B cells and antibody titer level against Epstein-Barr virus-associated nuclear antigen in healthy seropositive individuals.
    Kusunoki Y; Huang H; Fukuda Y; Ozaki K; Saito M; Hirai Y; Akiyama M
    Microbiol Immunol; 1993; 37(6):461-9. PubMed ID: 8231961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. II. Cytotoxic response to repeated stimulation.
    Allen DJ; Rickinson AB; Wallace LE; Rowe M; Moss DJ; Epstein MA
    Cell Immunol; 1982 Feb; 67(1):141-51. PubMed ID: 6176333
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of enhancement of Epstein-Barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, TPA, with special reference to lowering of cytotoxicity of T cells.
    Harada S; Katsuki T; Yamamoto H; Hinuma Y
    Int J Cancer; 1981 May; 27(5):617-23. PubMed ID: 6270019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus antibodies in multiple sclerosis.
    Sumaya CV; Myers LW; Ellison GW
    Arch Neurol; 1980 Feb; 37(2):94-6. PubMed ID: 6243930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro induction of cytotoxic T lymphocytes specific for Epstein-Barr virus-transformed cells: kinetics of autologous restimulation.
    Sugamura K; Hinuma Y
    J Immunol; 1980 Mar; 124(3):1045-9. PubMed ID: 6244347
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
    Aya T; Mizuno F; Osato T
    J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
    Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P
    Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformants.
    Burrows SR; Misko IS; Sculley TB; Schmidt C; Gang D; Moss DJ
    Cell Immunol; 1990 Apr; 127(1):47-55. PubMed ID: 1690609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
    Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
    Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis.
    Sumaya CV; Myers LW; Ellison GW; Ench Y
    Ann Neurol; 1985 Apr; 17(4):371-7. PubMed ID: 2988410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein.
    Bray PF; Luka J; Bray PF; Culp KW; Schlight JP
    Neurology; 1992 Sep; 42(9):1798-804. PubMed ID: 1381067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of lymphocytes from Epstein-Barr virus-seronegative donors by autologous Epstein-Barr virus-transformed cells.
    Chang RS; Chang YY
    J Infect Dis; 1980 Aug; 142(2):156-62. PubMed ID: 6251138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.